New Zealand Pompe Network
  • Home
  • About Us
    • NZPN Board
    • Affiliations
    • NZPN Membership
    • Our Patients >
      • Freda
      • Allyson
      • Christine
      • Dean
      • Samantha
      • Laurie
  • About Pompe
    • What is Pompe Disease?
    • Symptoms
    • Treatments
    • Recommended Links
  • News and views
    • NZPN Conference 2018 Summary
    • Press Releases
    • Personal Media Stories
    • Blog
    • Allyson's Florida Blog
    • PHARMAC & Govt >
      • Party stances on funding Rare Diseases
  • Diagnosing Kiwis
  • Clinical Trials
  • Glossary
  • Accessible NZ
  • Contact us
  • Living with Pompe
  • Donate

Treatments for Pompe Disease

I'll just make a small note here and say that while we may have this very rare and awful disease, it is great to know that there are so many people working on finding treatments and a cure for us ~ Allyson

Enzyme Replacement Therapy

Individuals with Pompe disease are best treated by a team of specialists (such as cardiologist, neurologist, and respiratory therapist) knowledgeable about the disease, who can offer supportive and symptomatic care. 

The discovery of the GAA gene has led to rapid progress in understanding the biological mechanisms and properties of the GAA enzyme.  As a result, an enzyme replacement therapy has been developed that has shown, in clinical trials with infantile-onset patients, to decrease heart size, maintain normal heart function, improve muscle function, tone, and strength, and reduce glycogen accumulation. 


Current treatments available:

Myozyme (Alglucosidase alfa). In the United States this drug is known as Lumizyme
Nexviazyme (Avalglucosidase alfa)

Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat)
​

Gene Therapy

As quoted from the AMDA website:

"Gene therapy will eventually be the cure for Pompe disease and other rare disorders. But until this dream is realized, enzyme replacement therapy offers hope in the near future for those affected by the devastation of Pompe disease".
​

Substrate Reduction Therapy

​Substrate Reduction Therapy for Pompe Disease: Small Molecule Inhibition of Glycogen Synthase 1 in Preclinical Models

Thank you for visiting us @ NZPN
  • Home
  • About Us
    • NZPN Board
    • Affiliations
    • NZPN Membership
    • Our Patients >
      • Freda
      • Allyson
      • Christine
      • Dean
      • Samantha
      • Laurie
  • About Pompe
    • What is Pompe Disease?
    • Symptoms
    • Treatments
    • Recommended Links
  • News and views
    • NZPN Conference 2018 Summary
    • Press Releases
    • Personal Media Stories
    • Blog
    • Allyson's Florida Blog
    • PHARMAC & Govt >
      • Party stances on funding Rare Diseases
  • Diagnosing Kiwis
  • Clinical Trials
  • Glossary
  • Accessible NZ
  • Contact us
  • Living with Pompe
  • Donate